Participations à des congrès et colloques internationaux (117)
39.
Sadeghi-Meibodi, N., Salmon, I., Wikler, D., Levivier, M., Massager, N., Tang, T., Rorive, S., Denolin, V., Balériaux, D., Metens, T., & Goldman, S. (2005). Dynamic Contrast-Enhanced Perfusion MRI in Brain Gliomas: Correlation with Methionine Metabolism and Histopathology. ISMRM. Vol. 13 (p. 369) Abstract session presented at Proc. Intl. Soc. Mag. Reson. Med.(Miami beach, USA).40.
Motte, S., Mathieu, M., Jonville, E., Ray, L., Pensis, A., Remmelink, M., Ketelslegers, J.-M., Salmon, I., Naeije, R., & McEntee, K. (2005). Biphasic modulation of endothelin-1 in canine experimental heart failure. Poster présenté à la conférence European Society of Cardiology (Juin 2005: Portugal).41.
Motte, S., Mathieu, M., Jonville, E., Ray, L., Pensis, A., Remmelink, M., Ketelslegers, J.-M., Salmon, I., Naeije, R., & McEntee, K. (2005). Biphasic modulation of endothelin-1 in canine experimental heart failure. Poster présenté à la conférence Société Belge de Physiologie et Pharmacologie (2005: Bruxelles).42.
Motte, S., Mathieu, M., Ray, L., Pensis, A., Remmelink, M., Ketelslegers, J.-M., Salmon, I., Naeije, R., & McEntee, K. (2005). Biphasic modulation of endothelin-1 in canine experimental heart failure. Poster présenté à la conférence European Society of cardiology, Heart failure (June: Lisbon).44.
Debelle, F., Nortier, J., De Prez, E., Salmon, I., Deschodt Lanckman, M., & Vanherweghem, J.-L. (2002). Inhition of the Renin-Angiotensin System (RAS) does not prevent renal fibrosis in a rat model of Chinese-Herb Nephropathy (CHN). Paper session presented at Annual Meeting and Scientific Exposition Submission Program (35: May 2002).45.
Lefranc, F., Chevalier, C., Ruchoux, M.-M., Gabius, H.-J., Salmon, I., & Kiss, R. (2002). Levels of expression of retinoic acid receptors, galectin-3, MIF and p53 in adamantinomatous craniopharyngiomas. Poster présenté à la conférence European Association for Neuro-Oncology Meeting (5th: September 7-10: Florence - Italy).46.
Lefranc, F., Camby, I., Bruyneel, E., Mareel, M., Salmon, I., & Kiss, R. (2002). Gastrin significantly modifies the migratory abilities of malignant astrocytic tumours. Poster présenté à la conférence European Association for Neuro-Oncology Meeting (5th: September 7-10: Florence - Italy).47.
Belot, N., Rorive, S., Lefranc, F., Decaestecker, C., Salmon, I., Kiss, R., & Camby, I. (2002). The molecular characterization of cell substratum attachments in human astrocytic tumours relates to pronostic features. Poster présenté à la conférence European Association for Neuro-Oncology Meeting (5th: September 7-10: Florence - Italy).48.
Camby, I., Belot, N., Lefranc, F., Sadeghi-Meibodi, N., Musette, S., Darro, F., Danguy, A., Salmon, I., Gabius, H.-J., & Kiss, R. (2002). Galectin-1 modulates the migration level and the aggressiveness of human glioblastoma cells in vitro and in vivo. Poster présenté à la conférence European Association for Neuro-Oncology Meeting (5th: September 7-10: Florence - Italy).49.
Branle, F., Lefranc, F., Camby, I., Jeuken, J., Sweep, F., Kiss, R., & Salmon, I. (2002). Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p/19q deletions and in C6 rat orthotopic allografts. Poster présenté à la conférence European Association for Neuro-Oncology Meeting (5th).